Nutex Health Inc.
NUTX
$44.66
-$1.84-3.96%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.57% | 12.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.57% | 12.79% | |||
| Cost of Revenue | 5.96% | -7.76% | |||
| Gross Profit | -0.76% | 88.90% | |||
| SG&A Expenses | 11.69% | 21.63% | |||
| Depreciation & Amortization | 9.70% | 8.28% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.17% | -2.87% | |||
| Operating Income | -15.72% | 725.75% | |||
| Income Before Tax | -166.10% | 2,655.04% | |||
| Income Tax Expenses | 412.86% | 129.38% | |||
| Earnings from Continuing Operations | -338.02% | 654.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 51.89% | -1,991.42% | |||
| Net Income | -2,314.37% | 0.03% | |||
| EBIT | -15.72% | 725.75% | |||
| EBITDA | -13.53% | 312.00% | |||
| EPS Basic | -2,250.89% | 2.40% | |||
| Normalized Basic EPS | -189.46% | 3,707.02% | |||
| EPS Diluted | -2,250.89% | 26.70% | |||
| Normalized Diluted EPS | -189.46% | 3,707.02% | |||
| Average Basic Shares Outstanding | 2.62% | 2.48% | |||
| Average Diluted Shares Outstanding | 2.62% | 2.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
